Latest technology reporting
Evidence-led coverage of biotechnology, AI infrastructure, energy, robotics, devices and brain–computer interfaces.
-
A Cancer-Fuelling Protein Becomes an Ally When Switched On in T Cells
PPARD can help tumours grow, yet boosting it in immune cells improved cancer control in laboratory models. The cell receiving the signal makes the difference.
-
An RNA-Splicing Gene Extends Mouse Lifespan in an Early Longevity Test
A gene-screening platform identified SRSF1 as a longevity candidate. Cells and a small mouse experiment offer a lead, with human safety still untested.
-
CERN’s Mistral Pact Turns Scientific AI Into a Data-Infrastructure Test
CERN and Mistral plan a foundation model trained on simulated particle collisions. The partnership will test whether shared models can serve scientific tasks at an immense data scale.
-
NVIDIA and Cisco’s New Optical Plug Targets the Space Between AI Machines
USFP aims to carry more data through a familiar-sized optical module. The announcement separates an initial 6.4 Tb/s design from a path to 12.8 Tb/s, with deployment evidence still ahead.
-
Venture Global’s 10 GW AI Power Ambition Starts With Conditional Equipment Deals
Venture Global’s new equipment frameworks could support large off-grid power projects. Reservations, orders, customer commitments and permitting still separate the ambition from operating capacity.
-
A DNA Typewriter Reconstructs the Ancestry of 1.28 Million Mouse Cells
A molecular recorder linked cell ancestry with cell identity across a developing mouse embryo. Its scale is striking, but the principal tree comes from one animal and remains incomplete.
-
Big Dogs’ Faster Molecular Ageing Puts Jumping Genes Under Scrutiny
A study of dog blood methylation links larger body size to faster molecular ageing. It identifies a possible mechanism to test, rather than a way to extend lifespan.
-
ARO-MAPT Lowers a Tau Marker With an Injection Under the Skin
Arrowhead reported sustained reductions in cerebrospinal-fluid tau in healthy volunteers. The early trial tests delivery and target engagement, not whether Alzheimer’s disease improves.
-
Anktiva’s Expanded Bladder-Cancer Approval Changes How Evidence Can Travel
The FDA expanded Anktiva plus BCG to high-grade papillary-only bladder cancer, drawing on earlier trial evidence and similarities between related tumour forms.
-
Marinus Link’s Heybridge Permit Clears a Planning Hurdle for the Converter Station
A tribunal affirmed the Heybridge converter-station permit, preserving its conditions. The decision advances one component of Marinus Link without making the undersea interconnector operational.
-
Tasmania’s AI Community Fund Moves the Data-Centre Debate Beyond Jobs
Tasmania expects major AI and data-centre developers to contribute to a community fund. The policy’s practical value will depend on contribution rules, transparency and local outcomes.
-
Adani and Jabil’s AI Hardware Pact Puts Rack Manufacturing Ahead of the Build
A proposed 50:50 venture would assemble AI racks, networking, power and cooling equipment in India. The non-binding agreement has not yet become an operating factory.